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Abstract
Introduction: MRI can be used to non-invasively monitor tumour growth and response to treatment in mouse models of
prostate cancer, particularly for longitudinal studies of orthotopically-implanted models. We have optimized the balanced
steady-state free precession (bSSFP) pulse sequence for mouse prostate imaging.
Methods: Phase cycling, excitations, flip angle and receiver bandwidth parameters were optimized for signal to noise ratio
and contrast to noise ratio of the prostate. The optimized bSSFP sequence was compared to T1- and T2-weighted spin echo
sequences.
Results: SNR and CNR increased with flip angle. As bandwidth increased, SNR, CNR and artifacts such as chemical shift
decreased. The final optimized sequence was 4 PC, 2 NEX, FA 50u,B W662.5 kHz and took 14–26 minutes with 200 mm
isotropic resolution. The SNR efficiency of the bSSFP images was higher than for T1WSE and T2WSE. CNR was highest for
T1WSE, followed closely by bSSFP, with the T2WSE having the lowest CNR. With the bSSFP images the whole body and
organs of interest including renal, iliac, inguinal and popliteal lymph nodes were visible.
Conclusion: We were able to obtain fast, high-resolution, high CNR images of the healthy mouse prostate with an
optimized bSSFP sequence.
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Introduction
Prostate cancer is the most-diagnosed non-melanoma cancer in
Canadian men and the third-leading cause of cancer death [1].
Mousemodels ofprostate cancerarevaluable forpre-clinical studies
of prostate cancer and include transgenic models such as the
Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) model
[2], and xenograft models [3–5] that typically involve subcutaneous
or orthotopic (intra-prostatic) injection of cancer cells. Subcutane-
ous tumours are easy to implant and measurable with calipers, but
orthotopic tumours are superior for studies in which metastasis is
desired [6–9]. In the case of intra-prostatatic tumours, without
imaging, tumour volume can only be estimated by palpation and
then measured after sacrifice, which requires a single measurement
for each animal and potentially a large number of animals with
separate groups of mice sacrificed at multiple timepoints.
Theuse ofmagneticresonanceimaging(MRI)allowsforthe non-
invasive quantification of tumor size, so that multiple timepoints are
measured in each animal, allowing for smaller sample sizes and
morecompletedata.Thereisalsotheopportunitytomanipulatethe
tissue contrast to better visualize the tissue of interest and to gain
different information about pathology. The prostate is adjacent to
thebladderandsurroundedbyfattytissue,whichmustbetakeninto
account when determining which imaging pulse sequence and
parameters to use. MRI has been used to monitor prostate tumour
growth in mice, primarily at high field strengths (.4T), but also at
clinical field strengths (1.5T and 3T). Most investigations have used
2D T1- or T2-weighted spin echo sequences (T1wSE and T2wSE),
but 3D imaging sequences have also been used [9–23].
The purpose of this study was to optimize 3D imaging of the
mouse prostate to achieve high SNR, high CNR and high
resolution between the prostate and surrounding tissues, using the
balanced steady state free precession (bSSFP) pulse sequence. This
SNR-efficient sequence has not previously been used for mouse
prostate imaging, and has the advantage of sensitivity to iron,
which will be useful in future studies of iron-labeled cell tracking in
a mouse model of prostate cancer.
Methods
Animals
Healthy male nude mice (5–12 weeks of age) were studied. Mice
were housed in a specific pathogen-free barrier facility in between
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Animal Use Subcommittee of the University Council on Animal
Care at The University of Western Ontario following the
guidelines of the Canadian Council on Animal Care (protocol #
2006-03).
MRI
Scans were performed on a 3T GE Excite MR750 system using
a custom-built high-performance gradient insert with an inner
diameter of 17.5 cm, maximum gradient strength of 500 mT/m
and peak slew rate of 3,000 T/m/s, and a custom solenoidal
whole-mouse body RF coil 4 cm in length and 3 cm in diameter.
For live mouse imaging, mice were anaesthetized with isoflurane
(2% in oxygen) and placed supine in the coil, warm saline bags
were taped near the RF coil to maintain body temperature, and
the mice were wrapped with gauze and tape for consistent
positioning and to minimize motion artifact due to respiration. For
ex vivo imaging, a mouse was euthanized by euthanyl then
immediately scanned in the same manner.
Images acquired using the bSSFP pulse sequence had the
following parameters at 200 mm isotropic spatial resolution. For
axial scans, the field of view (FOV) was 363 cm (14 minutes) or
464 cm (20 minutes), and for coronal scans it was 663.3 cm
(26 minutes). The flip angle (FA) was varied between 30u,4 0 u and
50u. The receiver bandwidth (BW) was varied from 631.25,
641.67, 662.5 and 683.3 kHz. Repetition time (TR) was
automatically set by the scanner software in accordance with
BW and FOV, and echo time (TE) was set to be half of TR. Thus,
TR ranged from 3.3–4.6 ms and TE from 1.7–2.3 ms. The
number of signal averages (NEX) ranged from 1–4. An RF phase
cycling scheme with a sum of squared reconstruction was
implemented and the number of phase cycles (PC) was varied
between 2–8. Axial bSSFP images (FOV 363 cm, 14 minutes)
were compared with the more traditionally-used spin echo (SE)
images acquired with the following parameters: axial orientation,
FOV 363 cm, TR/TE=600/25 ms (T1w), 2000/70 ms (T2w),
1 mm slice thickness, 1286128 matrix, 234 mm in-plane resolu-
tion, and acquisition time of 20 (T1w) or 17 (T2w) minutes.
Image Analysis
Images were compared based on signal to noise ratio (SNR),
contrast to noise ratio (CNR), and presence of artifacts such as
chemical shift. SNR was calculated as the mean signal from the
hindlimb muscle divided by the standard deviation of the
background signal. CNR was calculated as the difference in
SNR between the prostate and the surrounding fatty tissue. In
order to compare sequences with different scan times and slice
thicknesses, SNR efficiency was calculated as the SNR divided by
the square root of the scan time (in minutes) and was normalized
by slice thickness (in mm).
Results
Effect of phase cycles and averaging
Phase cycling is used with the bSSFP sequence to avoid the
appearance of characteristic dark banding artifacts that are caused
by sensitivity to local field inhomogeneities and which degrade
image quality considerably. Figure 1 shows the effect of phase
cycling (2, 4 and 8 PC) and averaging (4, 2 and 1 NEX) on
prostate image quality in a sacrificed mouse. All scans took
20 minutes. SNR values did not vary significantly with different
amounts of phase cycling, and CNR was highest for 4 PC, 2 NEX
and 8PC, 1 NEX. There was no banding artifact in any of the
images. The shape of the prostate in these ex vivo images is
different from the prostate in vivo due to deflation of the bladder
in the sacrificed mouse. For all future bSSFP acquisitions, 4 PC
and 2 NEX were used.
Effect of bandwidth and flip angle
When flip angles were compared, image SNR (based on muscle
signal) was approximately equal between flip angles, ranging from
20 to 23 (Figure 2). CNR increased with flip angle, with values of
40, 54 and 77 for 30u,4 0 u and 50u, respectively. With a flip angle
of 50u, the best SNR and CNR was obtained with a bandwidth of
631.25 kHz (SNR=25, CNR=116); however, there were
artifacts such as a slight chemical shift between the urethra and
prostate tissue, as well as a blurring of the edges of the prostate, at
the lowest bandwidth (D) compared to the highest bandwidth (F).
When the bandwidth was set to 662.5 kHz, the artifacts were
reduced with a higher CNR than was seen at a bandwidth of
683.5 kHz.
Comparison of bSSFP with T1w and T2w SE
Axial scans of a mouse were acquired with bSSFP with 4 PC, 2
NEX, FA 50u and BW 662.5 kHz (14 minutes) as determined
above and compared to T1wSE (20 min) and T2wSE (17 min)
scans with parameters as indicated in the methods section
(Figure 3). The T1wSE image had the highest CNR of the
Figure 1. Effect of phase cycling and averaging on ex vivo prostate image quality. Cropped and enlarged sections of axial scans: A: 2 PC, 4
NEX, B: 4 PC, 2 NEX, C: 8 PC, 1 NEX. Black arrowheads indicate prostate, white arrowheads urethra, FP is the fat pad used for CNR measurements and
LN are the inguinal lymph nodes. Scale bar is 1 cm. Axial scan, FOV 464 cm, 200 mm isotropic resolution, TR/TE=3.9/2.0 ms, FA 30u,B W662.5 kHz,
20 minutes.
doi:10.1371/journal.pone.0018361.g001
Mouse Prostate MRI with bSSFP Sequence
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the bSSFP image and 12 for the T2wSE. While the overall SNR
was highest for the T1wSE image at 41, it must be noted that the
slice thickness for the bSSFP, which had an SNR of 17, was
0.2 mm, compared to 1 mm for T1wSE. The SNR for the
T2wSE, also acquired with 1 mm slices, was 16. The SNR
efficiency was calculated and normalized by slice thickness: the
bSSFP had the largest SNR efficiency at 23, compared to 9 for the
T1wSE and 3 for the T2wSE.
3D nature of bSSFP
Since bSSFP is a 3-dimensional sequence, the image can be re-
oriented to view the prostate from any angle (Figure 4). This is
valuable to visualize the morphology and size of the prostate. A
simple re-orientation of the scan plane and enlargement of the
field of view allows for acquisition of whole mouse-body images, in
a short scan time, that include clear views of the prostate and other
organs of interest, such as lymph nodes and lymph vessels
(Figure 5).
Figure 2. Effect of flip angle and bandwidth on prostate visibility and artifacts. Flip angle of A: 30u vs B: 40u vs C: 50u at BW of 662.5 kHz.
Bandwidth of D: 631.25 kHz vs E: 662.5 kHz vs F: 683.3 kHz. Red arrowheads indicate prostate boundaries. White arrows point to fat pad used for
CNR calculations (FP) and to inguial lymph nodes (ILN). Scale bar is 1 cm. Scan parameters: Axial scan, FOV 363 cm, 200 mm isotropic resolution, TR/
TE=3.3–4.6 ms/1.1–2.3 ms, 4 PC, 2 NEX, 14 minutes.
doi:10.1371/journal.pone.0018361.g002
Figure 3. Comparison of in vivo axial views acquired with A: bSSFP, B: T1wSE and C: T2wSW. Black arrows indicate prostate, white arrows
indicate urethra. Scale bar is 1 cm. bSSFP images acquired using optimized sequence with 363 cm FOV. Spin echo sequences acquired with axial
orientation, FOV 363 cm, TR/TE=600/25 ms (T1w), 2000/70 ms (T2w), 1 mm slice thickness, 1286128 matrix, 234 mm in-plane resolution, and 20
(T1w) and 17 (T2w) minutes acquisition time.
doi:10.1371/journal.pone.0018361.g003
Mouse Prostate MRI with bSSFP Sequence
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MRI measurements of the mouse prostate are desirable for
visualizing the prostate over time with the flexibility of being able
to manipulate contrast. An advantage of MRI is sensitivity for
early detection: measurements of the long and short axes of the
prostate in 2D T1wSE images acquired at 7T were able to detect
prostate cancer 4 weeks sooner than by palpation [12,16].
Previous work on imaging the mouse prostate has been
primarily with 2-dimensional T1W [12,16,19,21] or T2W
[9,11,18–20,22,23] spin echo pulse sequences that provide only
a single orientation for viewing. With these 2D sequences it is often
necessary to use thick slices in order to obtain a reasonable SNR in
a reasonable scan time – these have been as high as 500–2000 mm
[14,15,19,22,23] sequences, although in one case it was reduced to
50 mm when field strength was increased to 4.7T from 1.5T [10].
In plane resolution is higher, typically ,100 mm. Three-
dimensional sequences such as T1W and T2W fast spin echo
and fast low angle shot also yield a variety of slice thicknesses from
300–2000 mm and in-plane resolutions of ,80–400 mm at clinical
and high field strengths [11,13–15,17].
Even at high field strength, scan time can be quite long, for
example 2.5 hours with an additional hour for setup [18]. While
this protocol at 7T allowed for impressive discrimination of the
ventral from the dorsolateral lobes of the prostate using a 2D
T2WSE sequence with CHESS (chemical shift selective sequence),
this scan time is impractical for studies involving more than a few
mice. More reasonable scan times of 10–15 minutes at 7T were
achieved through the use of techniques such as RARE and multi-
echo sequences [9,11].
Techniques for enhancing prostate contrast include using a long
TE and fat saturation in a 5–15 minute 2D fast spin-echo (FSE)
Figure 4. 3 views of prostate from one in-vivo scan. A: axial, B: coronal, C: sagittal. White arrows indicate prostate. Scale bar is 0.5 cm. Axial
scan, FOV 363 cm, 200 mm isotropic resolution, TR/TE=4.6 ms/2.3 ms, 4 PC, 2 NEX, FA 50u,B W662.5 kHz, 14 minutes.
doi:10.1371/journal.pone.0018361.g004
Figure 5. Sections of coronal view of mouse with prostate and lymph nodes identified. Tail is at left, head at right. White arrows indicate
organs of interest as follows. A: popliteal lymph nodes; B: prostate; C: iliac lymph nodes; D: inguinal lymph nodes with lymph vessels visible; E: Renal
lymph nodes. Scale bar is 0.5 cm. Coronal scan, FOV 663.3 cm, 200 mm isotropic resolution, TR/TE=4.6/2.3 ms, BW 662.5 kHz, FA 40u, 8 PC, 2 NEX,
26 minutes.
doi:10.1371/journal.pone.0018361.g005
Mouse Prostate MRI with bSSFP Sequence
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with fat suppression was used to obtain scans with 400 mm
isotropic voxel size in 10 minutes [17]. Additionally, fat suppres-
sion by saturation pre-pulses has been used at 7T [9,17–19].
Gadolinium has also been used to enhance contrast [21,24]. Other
methods of visualizing prostate tumours include using diffusion
weighted imaging, which improved detection of small tumours
(,1mm in diameter) compared to T2W imaging in a transgenic
mouse model of prostate cancer [20].
In this study, we did not use any additional contrast enhance-
ment techniques such as fat suppression; consequently, the seminal
vesicles were not detectable from the surrounding fat in healthy
mice. It is common for prostate tumours to spread to the seminal
vesicles; however, the seminal vesicles can be completely destroyed
by large prostate tumours [16], and the tumour-fat contrast may
be different from healthy seminal vesicle-fat contrast. Nevertheless,
it might be helpful in the future to exploit the chemical shift
artifact of the second kind to suppress mixed water-fat pixels using
a TE and TR such that the water and fat frequencies are out of
phase; fat-tissue interfaces would be black. However, the TR
would have to be increased, leading to a longer scan time [25].
The bSSFP pulse sequence is very SNR efficient and produces
unique T2/T1 contrast [26]. This sequence has been recently
applied to investigations of glioma in the mouse brain [27,28]. A
challenge presented by bSSFP, however, is its high sensitivity to
local field inhomogeneities. The result is a characteristic ‘‘banding
artifact’’ that worsens at higher field strengths and with longer TR
[26]. Multiple acquisition RF phase cycling techniques ameliorate
this problem and have allowed for bSSFP imaging at higher field
strengths and with longer TR [28,29].
Although the sensitivity of bSSFP to local field inhomogeneities
can be problematic, it has also been what has enabled this
sequence to be used for highly sensitive cellular imaging, which has
allowed the detection of iron-labeled single cells and cell clusters at
1.5 T and 3 T [30–35]. This feature of bSSFP may be useful in
mouse models of prostate cancer for detecting and monitoring
metastases.
We have obtained excellent high resolution, high SNR images
of the healthy mouse prostate in a relatively short scan time using
the bSSFP pulse sequence. For our mouse studies, this was
achieved using a custom-built high-performance gradient insert on
a clinical 1.5T system. While the maximum strength of the
insertable gradient coil used in this study is 500 mT/m, we
operated below this. For example, with receiver BW of 662 kHz,
and FOV of 3cm, (gamma is 4257 Hz/g), the strength of the
readout gradient is approximately 10g/cm=100mT/m [G(read-
out)=2*BW/(gamma*FOV)]. The gradient strength used to
excite the slab is also far below this maximum strength since a
thick slab is used that encompasses the whole mouse body. Clinical
gradients of 50 mT/m and higher are now available on whole
body scanners; therefore, b-SSFP protocols similar to that used in
this study are not out of the question for modern-day clinical
gradients.
In conclusion, this study shows that with optimized imaging
parameters, 3D mouse body images acquired with bSSFP allow
for the simultaneous visualization of the prostate and its draining
lymph nodes, the iliac and renal lymph nodes, as well as the
nearby inguinal and popliteal lymph nodes. The ability to detect
both the prostate and the lymph nodes in a single fast, high-
resolution scan will be useful for studies that aim to investigate
prostate cancer metastasis.
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